Difference between revisions of "Ferric gluconate (Ferrlecit)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA")
m (Text replacement - "[[Media:" to "[[File:")
Line 1: Line 1:
 
==General information==
 
==General information==
Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.<ref name="insert">[http://products.sanofi.us/ferrlecit/ferrlecit.pdf Ferric gluconate (Ferrlecit) package insert]</ref><ref>[[Media:Ferricgluconate.pdf | Ferric gluconate (Ferrlecit) package insert (locally hosted backup)]]</ref><ref>[http://www.ferrlecit.com/default.aspx Ferrlecit manufacturer's website]</ref>
+
Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.<ref name="insert">[http://products.sanofi.us/ferrlecit/ferrlecit.pdf Ferric gluconate (Ferrlecit) package insert]</ref><ref>[[File:Ferricgluconate.pdf | Ferric gluconate (Ferrlecit) package insert (locally hosted backup)]]</ref><ref>[http://www.ferrlecit.com/default.aspx Ferrlecit manufacturer's website]</ref>
 
<br>Route: IV
 
<br>Route: IV
 
<br>Extravasation: no information
 
<br>Extravasation: no information

Revision as of 00:26, 20 September 2021

General information

Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.[1][2][3]
Route: IV
Extravasation: no information

  • 1 mL of Ferrlecit provides 12.5 mg of elemental iron

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

History of changes in FDA indication

  • 2/18/1999: FDA approved "for treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoetin therapy."

Also known as

  • Generic name: sodium ferric gluconate complex in sucrose injection
  • Brand name: Ferrlecit

References